YOHIMBINE |
17ALPHA-HYDROXYYOHIMBAN-16ALPHA-CARBOXYLIC ACID METHYL ESTER |
QUEBRACHINE |
ACTIBINE® |
JOHIMBIN |
YOHIMBIN |
YOHIMBIC ACID METHYL ESTER |
QUEBRACHIN |
CORYNINE |
(16ALPHA,17ALPHA)-17-HYDROXYYOHIMBAN-16-CARBOXYLIC ACID METHYL ESTER |
APHRODINE |
(+)-YOHIMBINE |
chemidplus:146-48-5 |
chembl:CHEMBL15245 |
pubchem.compound:8969 |
rxcui:220982 |
drugbank:01392 |
Drug Class | anti-impotence agents |
Drug Class | mydriatics |
Year of Approval | not approved by the fda |
FDA Approval | not approved by the FDA |
Drug Class | small molecule |
Drug Indications | Anti-impotence Agents |
Drug Indications | Mydriatics |
Drug Categories | indole alkaloids |
Drug Groups | investigational |
Drug Categories | agents that produce hypertension |
Drug Categories | antidepressive agents |
Drug Categories | central nervous system depressants |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | dopamine antagonists |
Drug Categories | dopamine d2 receptor antagonists |
Drug Categories | heterocyclic compounds, fused-ring |
Drug Categories | other miscellaneous therapeutic agents |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | serotonergic drugs shown to increase risk of serotonin syndrome |
Drug Categories | serotonin 5-ht1 receptor antagonists |
Drug Categories | serotonin 5-ht2 receptor antagonists |
Drug Categories | serotonin agents |
Drug Categories | serotonin receptor antagonists |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
Direct Interaction? | True |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
partial agonist (activating) |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
antagonist (inhibitory) |
Specific Action of the Ligand | Antagonist |
Endogenous Drug? | False |
Yohimbine HCl 2mg | Drug Brand |
YOHIMBINE | DrugBank Drug Name |
146-48-5 | CAS Number |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
YOHIMBINE | Primary Drug Name |
Year of Approval | not approved by the fda |
Drug Class | mydriatics |
Drug Class | anti-impotence agents |
Drug Indications | Mydriatics |
Drug Indications | Anti-impotence Agents |
Drug Class | small molecule |
CHEMBL15245 | ChEMBL Drug ID |
D0H4JM | TTD Drug ID |
YOHIMBINE | GuideToPharmacology Ligand Name |